Login to Your Account



Blood Substitutes Struggle in Sea of Toxicity Concerns

By Tiffany Turner


Monday, May 26, 2008
Although blood shortages are common in much of the developing world and industrialized nations alike, the few players in the blood substitute market have much work to do to achieve success in that space. And it doesn't help that recent events threatened to send companies like Biopure Corporation, Hemosol BioPharma Inc. and Northfield Laboratories Inc. back to the starting block. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription